EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Primary Cutaneous Secretory Carcinoma of the Eyelid Margin: A Case Report

Eika Takano, Shinichi Nakazato iD, Takuya Otsuka iD, Mie Horiuchi, Susumu Honda, Chu Kimura

The Journal of Dermatology · 2026-07 · 53 (7)

DOI: 10.1111/1346-8138.70273 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 14.04.2026. Verfasst von Eika Takano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Hakodate Central General Hospital, Hakodate, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

apocrine glandcutaneous adnexal neoplasmdermatopathologyeyelid marginmoll's gland

Autor:innen und Institutionen

  • Department of Plastic Surgery, Hakodate Central General Hospital, Hakodate, Japan.
  • Department of Diagnostic Pathology, Hakodate Central General Hospital, Hakodate, Japan.
  • Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.

ORCID-Profile: Shinichi Nakazato, Takuya Otsuka

Zitieren

APA

Takano, E., Nakazato, S., Otsuka, T., Horiuchi, M., Honda, S., & Kimura, C. (2026). Primary Cutaneous Secretory Carcinoma of the Eyelid Margin: A Case Report. The Journal of Dermatology, 53(7). https://doi.org/10.1111/1346-8138.70273

Vancouver

Takano E, Nakazato S, Otsuka T, Horiuchi M, Honda S, Kimura C. Primary Cutaneous Secretory Carcinoma of the Eyelid Margin: A Case Report. The Journal of Dermatology. 2026;53(7). doi:10.1111/1346-8138.70273

BibTeX
@article{Takano2026,
  author = {Takano, Eika and Nakazato, Shinichi and Otsuka, Takuya and Horiuchi, Mie and Honda, Susumu and Kimura, Chu},
  title = {Primary Cutaneous Secretory Carcinoma of the Eyelid Margin: A Case Report},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {7},
  doi = {10.1111/1346-8138.70273}
}
Kostenlos starten →